TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia
Brief Summary: This study will integrate and adapt a cognitive remediation (Cognitive Enhancement Therapy \[CET\]) and an affect regulation (Personal Therapy \[PT\]) intervention for 50 individuals with schizophrenia that misuse cannabis. Participants will be randomized to CET/PT plus treatment as usual (TAU) or TAU alone and treated for 18 months.


Options:
A: Intervention Type: BEHAVIORAL; Name: Motivational Interview with care plan and education; Assigned to Arm(s): N/A
B: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard Care | Arm Label: Contingency management for abstinence from drugs; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management | Intervention Type: BEHAVIORAL; Name: contingency management; Assigned to Arm(s): Contingency management for abstinence from drugs | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
C: Arm Label: CET/PT; Type: EXPERIMENTAL; Interventions: Behavioral: CET/PT | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: CET/PT; Assigned to Arm(s): CET/PT | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Whole Grain Polyphenol Bioavailability and Effects on Inflammatory, Oxidative and Hormonal Status
Brief Summary: Whole grains (WG) contain numerous physiologically bioactive compounds, a key group being polyphenolic compounds such as ferulic acid (FA). These whole grain polyphenolic compounds have been shown to have potent antioxidant activity. This study will evaluate bioavailability of WG bioactive compounds and their physiological impact on health outcomes, mainly related to inflammatory, oxidative and hormonal status, in overweight subjects.


Options:
A: Arm Label: Whole grains; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Whole grains | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Whole grains; Assigned to Arm(s): Whole grains
B: Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: diet group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 50g-ONOG plus diet group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: organic naked oat with whole germ (ONOG) | Arm Label: 100g-ONOG plus diet group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: organic naked oat with whole germ (ONOG) | Intervention Type: DIETARY_SUPPLEMENT; Name: organic naked oat with whole germ (ONOG); Assigned to Arm(s): 100g-ONOG plus diet group, 50g-ONOG plus diet group
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Diet with increased intake of rye bread, berries and fish | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Increased intake of whole grain and rye bread | Arm Label: C; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Control diet with decreased intake of rye bread, berries and fish | Intervention Type: DIETARY_SUPPLEMENT; Name: Diet with increased intake of rye bread, berries and fish; Assigned to Arm(s): A | Intervention Type: DIETARY_SUPPLEMENT; Name: Increased intake of whole grain and rye bread; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Control diet with decreased intake of rye bread, berries and fish; Assigned to Arm(s): C
D: Intervention Type: DIETARY_SUPPLEMENT; Name: Ls-33; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace
Brief Summary: Many adults find it difficult to perform physical exercise during leisure. The workplace may provide an optimal setting to encourage a healthier lifestyle. This study investigates the effect of daily stair walking at the workplace on cardiovascular health.

The main hypothesis is that daily stair walking for 10 weeks compared with a control group results in increased aerobic fitness.


Options:
A: Arm Label: Stair walking; Type: EXPERIMENTAL; Interventions: Behavioral: Stair walking | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stair walking | Intervention Type: BEHAVIORAL; Name: Stair walking; Assigned to Arm(s): Control, Stair walking
B: Arm Label: AIT: aerobic interval training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic interval training | Arm Label: MIT, moderate intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: moderate intensity training | Arm Label: Recommendation of regular exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Recommendation of regular exercise | Intervention Type: BEHAVIORAL; Name: Aerobic interval training; Assigned to Arm(s): AIT: aerobic interval training | Intervention Type: BEHAVIORAL; Name: moderate intensity training; Assigned to Arm(s): MIT, moderate intensity training | Intervention Type: BEHAVIORAL; Name: Recommendation of regular exercise; Assigned to Arm(s): Recommendation of regular exercise
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Group mediated cognitive behavioral (GMCB) sessions | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Health education sessions | Intervention Type: BEHAVIORAL; Name: Group mediated cognitive behavioral (GMCB) sessions; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Health education sessions; Assigned to Arm(s): 2
D: Arm Label: pedometer-plus-email; Type: EXPERIMENTAL; Interventions: Behavioral: pedometer-plus-email | Arm Label: pedometer-only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: pedometer-only | Intervention Type: BEHAVIORAL; Name: pedometer-plus-email; Assigned to Arm(s): pedometer-plus-email | Intervention Type: BEHAVIORAL; Name: pedometer-only; Assigned to Arm(s): pedometer-only

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace
Brief Summary: Many adults find it difficult to perform physical exercise during leisure. The workplace may provide an optimal setting to encourage a healthier lifestyle. This study investigates the effect of daily stair walking at the workplace on cardiovascular health.

The main hypothesis is that daily stair walking for 10 weeks compared with a control group results in increased aerobic fitness.


Options:
A: Arm Label: Physical activity treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Pedal@Work | Arm Label: Wait List Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pedal@Work Worksite Wellness | Intervention Type: BEHAVIORAL; Name: Pedal@Work Worksite Wellness; Assigned to Arm(s): Wait List Control | Intervention Type: BEHAVIORAL; Name: Pedal@Work; Assigned to Arm(s): Physical activity treatment group
B: Arm Label: Stair walking; Type: EXPERIMENTAL; Interventions: Behavioral: Stair walking | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stair walking | Intervention Type: BEHAVIORAL; Name: Stair walking; Assigned to Arm(s): Control, Stair walking
C: Arm Label: Directive; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Directive smoking cessation coaching | Arm Label: Nondirective; Type: EXPERIMENTAL; Interventions: Behavioral: Nondirective smoking cessation coaching | Intervention Type: BEHAVIORAL; Name: Nondirective smoking cessation coaching; Assigned to Arm(s): Nondirective | Intervention Type: BEHAVIORAL; Name: Directive smoking cessation coaching; Assigned to Arm(s): Directive
D: Arm Label: Tailored Physical Activity; Type: EXPERIMENTAL; Interventions: Other: Tailored Physical Activity | Arm Label: Reference group; Type: OTHER; Interventions: Behavioral: Health Counselling | Intervention Type: OTHER; Name: Tailored Physical Activity; Assigned to Arm(s): Tailored Physical Activity | Intervention Type: BEHAVIORAL; Name: Health Counselling; Assigned to Arm(s): Reference group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observational Study to Assess Clinical Management Patterns in Patients With Hospitalised Community-Acquired Pneumonia (CAP) or Complicated Skin and Skin Structure Infections (cSSSI)
Brief Summary: This study will collect real-life data from patients with community acquired pneumonia (CAP) OR complicated skin and skin structure infections (cSSSI) to assess the burden of the disease, review the treatment pathways, evaluate how health resources are used and identify any areas of unmet medical needs. The aim of the study is to compare how patients who are admitted to hospital with CAP or cSSSI are managed across Europe. This will be done by collecting data to understand the patient and disease characteristics, current practice of treatment, and outcomes for the patient. Overall 4000 patients will be recruited from 10 European countries.


Options:
A: Arm Label: 1: Hygiene Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive education on personal hygiene | Arm Label: 2: Hygiene education + mupirocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Behavioral: Intensive education on personal hygiene | Arm Label: Education + mupirocin + chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Genetic: Chlorhexidine showers, Behavioral: Intensive education on personal hygiene | Arm Label: 4: Education + mupirocin + bleach baths; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mupirocin ointment, Procedure: Bleach baths (dilute), Behavioral: Intensive education on personal hygiene | Intervention Type: DRUG; Name: Mupirocin ointment; Assigned to Arm(s): 2: Hygiene education + mupirocin, 4: Education + mupirocin + bleach baths, Education + mupirocin + chlorhexidine | Intervention Type: GENETIC; Name: Chlorhexidine showers; Assigned to Arm(s): Education + mupirocin + chlorhexidine | Intervention Type: PROCEDURE; Name: Bleach baths (dilute); Assigned to Arm(s): 4: Education + mupirocin + bleach baths | Intervention Type: BEHAVIORAL; Name: Intensive education on personal hygiene; Assigned to Arm(s): 1: Hygiene Education, 2: Hygiene education + mupirocin, 4: Education + mupirocin + bleach baths, Education + mupirocin + chlorhexidine
B: Arm Label: Single-Dose IV Oritavancin Diphosphate; Type: EXPERIMENTAL; Interventions: Drug: Single-Dose IV Oritavancin Diphosphate, Drug: Placebo | Arm Label: IV Vancomycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Vancomycin | Intervention Type: DRUG; Name: Single-Dose IV Oritavancin Diphosphate; Assigned to Arm(s): Single-Dose IV Oritavancin Diphosphate | Intervention Type: DRUG; Name: IV Vancomycin; Assigned to Arm(s): IV Vancomycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Single-Dose IV Oritavancin Diphosphate
C: Intervention Type: DRUG; Name: antimicrobial agent in soap; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion: A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine, in a pilot setting, if this study is feasible in terms of recruitment, willingness to be randomized, provision of contraceptive methods, and follow-up. The investigators hypothesize that this pilot study will be feasible in terms of recruitment, provision of care, and follow-up.

The study will be a pilot randomized controlled trial comparing outcomes of immediate post-placental insertion of the Copper T 380A (Group 1) to outcomes of interval insertion of the Copper T 380A performed 6 weeks after delivery (Group 2) for patients undergoing scheduled cesarean delivery at Mulago Hospital in Kampala, Uganda. This study will not be powered to detect a difference, but rather the investigators will enroll all eligible and interested women during the three-month enrollment period. Potential participants who do not choose an IUD or who choose not to participate will be offered an anonymous opt-out survey.


Options:
A: Arm Label: postplacental insertion after cesarean; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Arm Label: delayed insertion group; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): postplacental insertion after cesarean | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): delayed insertion group
B: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval
C: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
D: Arm Label: 6 weeks interval insertion; Type: OTHER; Interventions: Other: 6 weeks interval insertion | Arm Label: Immediate insertion; Type: EXPERIMENTAL; Interventions: Other: Immediate insertion | Intervention Type: OTHER; Name: Immediate insertion; Assigned to Arm(s): Immediate insertion | Intervention Type: OTHER; Name: 6 weeks interval insertion; Assigned to Arm(s): 6 weeks interval insertion

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion: A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine, in a pilot setting, if this study is feasible in terms of recruitment, willingness to be randomized, provision of contraceptive methods, and follow-up. The investigators hypothesize that this pilot study will be feasible in terms of recruitment, provision of care, and follow-up.

The study will be a pilot randomized controlled trial comparing outcomes of immediate post-placental insertion of the Copper T 380A (Group 1) to outcomes of interval insertion of the Copper T 380A performed 6 weeks after delivery (Group 2) for patients undergoing scheduled cesarean delivery at Mulago Hospital in Kampala, Uganda. This study will not be powered to detect a difference, but rather the investigators will enroll all eligible and interested women during the three-month enrollment period. Potential participants who do not choose an IUD or who choose not to participate will be offered an anonymous opt-out survey.


Options:
A: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
B: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
C: Arm Label: 6 weeks interval insertion; Type: OTHER; Interventions: Other: 6 weeks interval insertion | Arm Label: Immediate insertion; Type: EXPERIMENTAL; Interventions: Other: Immediate insertion | Intervention Type: OTHER; Name: Immediate insertion; Assigned to Arm(s): Immediate insertion | Intervention Type: OTHER; Name: 6 weeks interval insertion; Assigned to Arm(s): 6 weeks interval insertion
D: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Brief Summary: Fibromyalgia syndrome (FM) shares many symptoms common to chronic neuropathic pain, including the characteristic hyperalgesia of the skin (thermal, mechanical) and muscles (mechanical) found in almost all FM patients. Milnacipran, a balance norepinephrine-serotonin re-uptake inhibitor, has been found to reduce pain and improve physical function of FM patients. However, little is known about the pain mechanisms that are affected by this medication. Therefore, the investigator wants to determine the efficacy of milnacipran in reducing pain as well as mechanical and thermal hyperalgesia of FM patients during a randomized, double-blind, placebo controlled trial. Because the investigator expects anti-hyperalgesic effects to coincide or precede with effects on clinical FM pain the proposed duration for this trial is 6 weeks.


Options:
A: Arm Label: Duloxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo oral tablet | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo oral tablet; Assigned to Arm(s): Placebo
B: Arm Label: Duloxetine 60 mg; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine 60 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine 60 mg; Assigned to Arm(s): Duloxetine 60 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Milnacipran | Arm Label: Milnacipran; Type: ACTIVE_COMPARATOR; Interventions: Drug: Milnacipran | Intervention Type: DRUG; Name: Milnacipran; Assigned to Arm(s): Milnacipran, Sugar pill
D: Arm Label: Imipramine treatment; Type: EXPERIMENTAL; Interventions: Drug: Imipramine treatment | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Imipramine treatment; Assigned to Arm(s): Imipramine treatment | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Brief Summary: The purpose of the study is to evaluate the safety and effectiveness of the UroLift(R) System when used in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the improvement of International Prostate Symptom Score (IPSS) and safety will be reviewed based on pertinent adverse events.


Options:
A: Arm Label: UroLift System; Type: ACTIVE_COMPARATOR; Interventions: Device: UroLift System | Arm Label: Transurethral Resection of the Prostate; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transurethral Resection of the Prostate | Intervention Type: DEVICE; Name: UroLift System; Assigned to Arm(s): UroLift System | Intervention Type: PROCEDURE; Name: Transurethral Resection of the Prostate; Assigned to Arm(s): Transurethral Resection of the Prostate
B: Arm Label: UroLift System; Type: ACTIVE_COMPARATOR; Interventions: Device: UroLift System | Arm Label: Cystoscopy; Type: SHAM_COMPARATOR; Interventions: Other: Cystoscopy | Arm Label: Crossover; Type: ACTIVE_COMPARATOR; Interventions: Device: Crossover | Intervention Type: DEVICE; Name: UroLift System; Assigned to Arm(s): UroLift System | Intervention Type: OTHER; Name: Cystoscopy; Assigned to Arm(s): Cystoscopy | Intervention Type: DEVICE; Name: Crossover; Assigned to Arm(s): Crossover
C: Arm Label: Prostatic artery embolization; Type: EXPERIMENTAL; Interventions: Procedure: Prostatic artery embolization | Arm Label: Conventional monopolar transurethral prostatectomy; Type: OTHER; Interventions: Procedure: monopolar transurethral prostatectomy | Intervention Type: PROCEDURE; Name: Prostatic artery embolization; Assigned to Arm(s): Prostatic artery embolization | Intervention Type: PROCEDURE; Name: monopolar transurethral prostatectomy; Assigned to Arm(s): Conventional monopolar transurethral prostatectomy
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Device: Rezum System | Arm Label: Control; Type: OTHER; Interventions: Procedure: Rigid Cystoscopy | Intervention Type: DEVICE; Name: Rezum System; Assigned to Arm(s): Treatment | Intervention Type: PROCEDURE; Name: Rigid Cystoscopy; Assigned to Arm(s): Control

Answer: B